4,6-Difluoro-1H-benzo[d]imidazol-2(3H)-one

Catalog No.: 
ACZXBA341
CAS No.: 
1221793-66-3
Molecular Formula: 
C7H4F2N2O
Molecular Weight: 
170.12
4,6-Difluoro-1H-benzo[d]imidazol-2(3H)-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g96%
25g96%
100g96%

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4,6-Difluoro-1H-benzo[d]imidazol-2(3H)-one
IUPAC Name4,6-difluoro-1,3-dihydro-2H-benzo[d]imidazol-2-one
MDL No.MFCD16036122
Molecular FormulaC7H4F2N2O
Molecular Weight170.12
SMILESO=C1NC2=CC(F)=CC(F)=C2N1
InChI KeyWYUDQMPZFGJEFY-UHFFFAOYSA-N
Synonym4,6-Difluoro-1H-benzo[d]imidazol-2(3H)-one | 1221793-66-3 | 4,6-difluoro-1,3-dihydrobenzimidazol-2-one | 2H-Benzimidazol-2-one, 4,6-difluoro-1,3-dihydro- | SCHEMBL8873233 | SCHEMBL20919828 | DTXSID70633304 | MFCD16036122 | AKOS006334203 | AKOS017407152 | AT32411 | BS-21257 | BB
CAS No.1221793-66-3
PubChem CID23354131

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACZXBA341 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACGTJF497 route compound structure diagram
    ACGTJF4972369-29-1In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZXBA341 route product structure diagram
    ACZXBA3411221793-66-3In Stock
Inquiry

2. ACZXBA341 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZXBA341 route product structure diagram
    ACZXBA3411221793-66-3In Stock
Inquiry

3. ACZXBA341 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZXBA341 route product structure diagram
    ACZXBA3411221793-66-3In Stock
Inquiry

Comments (0)